97 results on '"Picchio"'
Search Results
2. PD19-10 PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: UPDATED RESULTS OF A PLANNED INTERIM ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY
3. PD61-03 EXTERNAL VALIDATION OF THE AVAILABLE NOMOGRAMS FOR THE IDENTIFICATION OF CANDIDATES FOR a STAGING EXTENDED PELVIC LYMPH NODE DISSECTION AT THE TIME OF RADICAL PROSTATECTOMY IN PROSTATE CANCER PATIENTS PREOPERATIVELY STAGED WITH PSMA PET
4. MP14-10 IDENTIFYING THE OPTIMAL CANDIDATE FOR CONCOMITANT ANDROGEN-DEPRIVATION THERAPY AMONG PATIENTS RECEIVING METASTASIS-DIRECTED THERAPY FOR POSITIVE PSMA PET AND PRIMARY OR SECONDARY BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER
5. MP14-13 EXPLORING THE INTERACTION BETWEEN THE USE OF METASTASIS DIRECTED THERAPY IN PATIENTS WITH POSITIVE PSMA PET AND PATTERNS OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY. RESULTS OF A LARGE, SINGLE INSTITUTION SERIES
6. MP14-11 THE ADDED VALUE OF CONCOMITANT WHOLE-PELVIS SALVAGE RADIATION THERAPY IN OLIGO-RECURRENT PROSTATE CANCER PATIENTS TREATED WITH METASTASIS-DIRECTED THERAPY FOR DISTANT POSITIVE UPTAKES AT PSMA PET
7. MP14-01 RATES AND PREDICTORS OF FALSE NODE-POSITIVE PSMA-PET IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND EXTEND PELVIC LYMPH-NODE DISSECTION: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL DATABASE
8. MP14-04 THE ROLE OF PSA DOUBLING TIME IN THE STRATIFICATION OF PATIENTS WITH A NEGATIVE PSMA PET AFTER BIOCHEMICAL RECURRENCE OF PROSTATE CANCER: IMPLICATIONS FOR TAILORED SALVAGE TREATMENT STRATEGIES
9. MP31-19 “THE MORE YOU SEE THE MORE YOU MISS” PSMA PET/CT IS STILL AFFECTED BY A SUBSTANTIAL RISK OF UNDERESTIMATION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY
10. MP14-18 ONCOLOGICAL OUTCOMES OF PN1 PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: DOES MOLECULAR IMAGING HAVE A PROGNOSTIC IMPACT? RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
11. MP40-14 ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?
12. MP61-14 PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: UPDATED RESULTS OF PLANNED INTERIM ANALYSES OF A PROSPECTIVE PHASE 2 STUDY
13. PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCALIZED PROSTATE CANCER
14. PD10-08 THE PROGNOSTIC IMPACT OF PREOPERATIVE PSMA-PET ON EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-CENTER ANALYSIS
15. PD10-07 CAN WE RELY ON AVAILABLE MODELS TO IDENTIFY CANDIDATES FOR EXTENDED PELVIC LYMPH NODE DISSECTION (EPLND) IN MEN STAGED WITH PSMA-PET? EXTERNAL VALIDATION OF THE BRIGANTI NOMOGRAMS AND DEVELOPMENT OF A NOVEL TOOL TO IDENTIFY OPTIMAL CANDIDATES FOR EPLND
16. MP40-14 ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?
17. PD10-08 THE PROGNOSTIC IMPACT OF PREOPERATIVE PSMA-PET ON EARLY ONCOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY: RESULTS OF A MULTI-CENTER ANALYSIS
18. MP61-14 PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING ROBOT-ASSISTED RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: UPDATED RESULTS OF PLANNED INTERIM ANALYSES OF A PROSPECTIVE PHASE 2 STUDY
19. PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCALIZED PROSTATE CANCER
20. V11-02 99M-TECHNETIUM-PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: A PHASE 2 PROSPECTIVE, SINGLE-INSTITUTION STUDY
21. MP51-15 THE ROLE OF 68 GA-PSMA- AND 68 GA-DOTA-RM2 PET/MRI IN THE PRIMARY STAGING OF HIGH-RISK PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY. PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER STUDY
22. V11-02 99M-TECHNETIUM-PSMA RADIO-GUIDED SURGERY TO DETECT NODAL METASTASES IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION: A PHASE 2 PROSPECTIVE, SINGLE-INSTITUTION STUDY
23. MP51-15 THE ROLE OF 68 GA-PSMA- AND 68 GA-DOTA-RM2 PET/MRI IN THE PRIMARY STAGING OF HIGH-RISK PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY. PRELIMINARY RESULTS OF A PROSPECTIVE, SINGLE CENTER STUDY
24. PD17-09 DEVELOPMENT OF A NOVEL RISK STRATIFICATION FOR PROSTATE CANCER PATIENTS CANDIDATE TO RADICAL PROSTATECTOMY STAGED WITH PREOPERATIVE PSMA-PET: THE KEY ROLE OF MOLECULAR IMAGING.
25. MP36-16 THE ROLE OF HISTOLOGIC SUBTYPES IN FOLLOW-UP SCHEME OF POSTSURGICAL KIDNEY CANCER PATIENTS
26. [ 11 C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging
27. MP36-16 THE ROLE OF HISTOLOGIC SUBTYPES IN FOLLOW-UP SCHEME OF POSTSURGICAL KIDNEY CANCER PATIENTS
28. PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY
29. PD38-12 [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAÏVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
30. PD15-07 ASSESSING THE OPTIMAL EXTENT OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH SINGLE PELVIC NODAL UPTAKE AT [11C]-CHOLINE PET/CT SCAN FROM RECURRING PROSTATE CANCER
31. 178 A SINGLE SPOT AT [(11)C]CHOLINE-PET/CT SCAN IS NOT PREDICTIVE OF A SINGLE, ISOLATED NODAL METASTASIS AT FINAL PATHOLOGY. IMPLICATIONS FOR SALVAGE TREATMENTS
32. 187 IS [11C]CHOLINE PET/CT RECOMMENDED FOR RESTAGING PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY WHEN PSA IS LOWER THAN 1 NG/ML?
33. 182 EVALUATION OF LYMPH NODE RECURRENT PROSTATE CANCER WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL PROSTATECTOMY: VALIDATION BY HISTOLOGICAL ANALYSIS
34. 2017 FACTORS PREDICTING POSITIVE [11C]CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
35. PD38-12 [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAÏVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
36. PD15-07 ASSESSING THE OPTIMAL EXTENT OF SALVAGE LYMPH NODE DISSECTION IN PATIENTS WITH SINGLE PELVIC NODAL UPTAKE AT [11C]-CHOLINE PET/CT SCAN FROM RECURRING PROSTATE CANCER
37. [ 11 C]Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen
38. 182 EVALUATION OF LYMPH NODE RECURRENT PROSTATE CANCER WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL PROSTATECTOMY: VALIDATION BY HISTOLOGICAL ANALYSIS
39. 187 IS [11C]CHOLINE PET/CT RECOMMENDED FOR RESTAGING PROSTATE CANCER PATIENTS AFTER RADICAL PROSTATECTOMY WHEN PSA IS LOWER THAN 1 NG/ML?
40. 178 A SINGLE SPOT AT [(11)C]CHOLINE-PET/CT SCAN IS NOT PREDICTIVE OF A SINGLE, ISOLATED NODAL METASTASIS AT FINAL PATHOLOGY. IMPLICATIONS FOR SALVAGE TREATMENTS
41. 2017 FACTORS PREDICTING POSITIVE [11C]CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
42. VALIDATION OF THE CRITERIA SUGGESTED BY CURRENT GUIDELINES TO INDICATE THE NEED FOR BASELINE STAGING BONE SCAN IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER
43. DETECTION OF LYMPH-NODE METASTASES WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY: VALIDATION BY OPEN PELVIC-RETROPERITONEAL LYMPHADENECTOMY
44. A NOVEL NOMOGRAM PREDICTING A POSITIVE [ 11 C]CHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/TC) SCAN IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
45. A NOVEL NOMOGRAM PREDICTING A POSITIVE [ 11 C]CHOLINE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (PET/TC) SCAN IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
46. VALIDATION OF THE CRITERIA SUGGESTED BY CURRENT GUIDELINES TO INDICATE THE NEED FOR BASELINE STAGING BONE SCAN IN PATIENTS WITH NEWLY DIAGNOSED PROSTATE CANCER
47. DETECTION OF LYMPH-NODE METASTASES WITH INTEGRATED [11C]CHOLINE PET/CT IN PATIENTS WITH PSA FAILURE AFTER RADICAL RETROPUBIC PROSTATECTOMY: VALIDATION BY OPEN PELVIC-RETROPERITONEAL LYMPHADENECTOMY
48. 1555: The Role of Integrated 11C-Choline Pet/CT Scan in Re-Staging Patients with Biochemical Failure after Radical Retropubic Prostatectomy: Hystologic Correlations after Pelvic or Retroperitoneal Lympho-Node Dissection
49. 1555: The Role of Integrated 11C-Choline Pet/CT Scan in Re-Staging Patients with Biochemical Failure after Radical Retropubic Prostatectomy: Hystologic Correlations after Pelvic or Retroperitoneal Lympho-Node Dissection
50. Value of [ 11 C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ 18 F]fluorodeoxyglucose-Positron Emission Tomography
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.